PharmTech News

Apr 05, 2018
By Pharmaceutical Technology Editors
Fujifilm acquires cell culture media companies Irvine Scientific Sales Company and IS Japan.
Apr 05, 2018
By Pharmaceutical Technology Editors
The European approval marks the first approval for a biosimilar in that region resulting from the companies’ joint portfolio.
Apr 05, 2018
By Pharmaceutical Technology Editors
The contract development and manufacturing organization announced the addition of a new building complex that will house its headquarters in Bothell, WA.
Apr 05, 2018
By Pharmaceutical Technology Editors
The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.
Apr 05, 2018
By Pharmaceutical Technology Editors
Colorcon Inc. and Applied DNA signed a supply agreement granting Colorcon exclusive right to use Applied DNA’s SigNature molecular tags in film coatings for solid oral dosage forms, and non-exclusive rights to use it in inks and colorants for SOD pharmaceuticals.
Apr 03, 2018
By Pharmaceutical Technology Editors
Pfizer transfers CAR-T assets to Allogene Therapeutics under a new alliance to further develop immuno-oncology therapeutics.
Apr 03, 2018
By Pharmaceutical Technology Editors
The agency has accepted AstraZeneca’s biologics license application for an investigational leukemia drug candidate and granted it priority review.
Apr 03, 2018
By Pharmaceutical Technology Editors
The agency has release a report providing an overview of steps taken to enhance benefit-risk assessment in the review of drugs.
Apr 03, 2018
By Pharmaceutical Technology Editors
The company is recalling Pasta De Lassar Andromaco zinc oxide diaper rash treatment after FDA analysis confirmed the product contained high levels of yeast, mold, and bacteria.
Apr 03, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
A new scientific publication examines analytical processes for the emerging legal cannabis industry.
native1_300x100
lorem ipsum